Hypnotic drug use in Spain: a cross-sectional study based on a network of community pharmacies. Spanish Group for the Study of Hypnotic Drug Utilization.
OBJECTIVE
To investigate how hypnotic drugs are used in Spain, specifically, (1) to characterize the user population in some simple demographic (e.g., sex, age) and clinical (e.g., type of insomnia, type of physician who prescribed the drug) variables; (2) to estimate the proportion of long-term users (> 3 mo); (3) to determine the frequency of different administration schedules; (4) to determine whether the kind of hypnotic drug prescribed according to the duration of its effect correlates with the type of sleep disorder or patient age; and (5) to compare the dosage used by the elderly with that used by adults.


METHODS
Cross-sectional pharmacy-based study.


METHODS
A network of 318 community pharmacies throughout Spain.


METHODS
Patients (n = 5324) requesting a hypnotic drug for insomnia who agreed to take part in the study.


METHODS
Distribution of the use of hypnotic drugs by age, sex, type of insomnia, type of physician, specific hypnotic drug, daily dosage, treatment schedule, and duration of treatment.


RESULTS
Women (67%) and the elderly (58%) constituted the largest subgroups in the sample. Difficulties in sleep onset and in sleep maintenance as single disorders were reported by 38% and 37% of users, respectively. Prescriptions were written by general practitioners in 80% of cases. Daily use was reported by 88% and long-term use (> 3 mo) by 72% of the users. Long-term treatment was two- to threefold more frequent in the elderly than in middle-aged subjects. Intermediate-action hypnotic drugs were used by 59% of subjects, short-action drug by 24%, and long-action drugs by 17%. The type of hypnotic drug prescribed was not related to the kind of sleep disorder or the age of patients. Specialists prescribed long-action hypnotic drugs more often than did general practitioners. No relevant differences were observed between dosages used by the elderly and those used by adults. In both groups the dosage taken by most patients, regardless of the drug, corresponded to the available strength. Substitution drugs for triazolam belonged to the intermediate-action class in 53% of the cases.


CONCLUSIONS
Recommendations on hypnotic drug use are largely not followed in Spain. Most patients are taking hypnotic drugs daily, over long time periods, and without an adequate dosage titration according to age. Measures should be taken to correct this situation.
Centro Nacional de Farmacobiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
P
P
Rayón
M
M
Serrano-Castro
H
H
del Barrio
C
C
Alvarez
D
D
Montero
M
M
Madurga
R
R
Palop
F J
FJ
DeAbajo
D000284:Administration, Oral; D000368:Aged; D004305:Dose-Response Relationship, Drug; D004335:Drug and Narcotic Control; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010594:Pharmacies; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D013030:Spain; D014229:Triazolam / Q000008:administration & dosage
D006993:Hypnotics and Sedatives; D014229:Triazolam